• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Rituximab Prevents Stroke Recurrences in Atypical Chronic Immune-Mediated Thrombotic Thrombocytopenic Purpura.

作者信息

Dupuy Henry, Lazaro Estibaliz, Machelart Irène, Viallard Jean-François, Coppo Paul, Rivière Etienne

机构信息

Department of Internal Medicine and Infectious Diseases, University Hospital Center of Bordeaux, Haut-Leveque Hospital, Pessac, France.

ImmunoconcEpT and FHU ACRONIM, UMR CNRS 5164, Bordeaux, France.

出版信息

TH Open. 2018 Dec 5;2(4):e407-e410. doi: 10.1055/s-0038-1676357. eCollection 2018 Oct.

DOI:10.1055/s-0038-1676357
PMID:31249968
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6524916/
Abstract
摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d418/6524916/17d892616ddc/10-1055-s-0038-1676357-i180049-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d418/6524916/17d892616ddc/10-1055-s-0038-1676357-i180049-1.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d418/6524916/17d892616ddc/10-1055-s-0038-1676357-i180049-1.jpg

相似文献

1
Rituximab Prevents Stroke Recurrences in Atypical Chronic Immune-Mediated Thrombotic Thrombocytopenic Purpura.利妥昔单抗可预防非典型慢性免疫介导性血栓性血小板减少性紫癜的中风复发。
TH Open. 2018 Dec 5;2(4):e407-e410. doi: 10.1055/s-0038-1676357. eCollection 2018 Oct.
2
Post-Partum Thrombotic Thrombocytopenic Purpura (TTP) in a Patient with known Idiopathic (Immune) Thrombocytopenic Purpura: a case report and review of the literature.一名已知患有特发性（免疫性）血小板减少性紫癜的患者发生产后血栓性血小板减少性紫癜：病例报告及文献综述
J Med Case Rep. 2018 Jun 1;12(1):147. doi: 10.1186/s13256-018-1692-1.
3
A dramatic response to rituximab in a patient with resistant thrombotic thrombocytopenic purpura (TTP) who developed acute stroke.一名患有难治性血栓性血小板减少性紫癜（TTP）并发生急性中风的患者对利妥昔单抗产生显著反应。
J Thromb Thrombolysis. 2007 Apr;23(2):147-50. doi: 10.1007/s11239-006-9051-2. Epub 2007 Jan 13.
4
Immunotherapy for thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜的免疫疗法。
Curr Opin Hematol. 2005 Sep;12(5):359-63. doi: 10.1097/01.moh.0000170534.33517.99.
5
Refractory thrombotic thrombocytopenic purpura and membranoproliferative glomerulonephritis successfully treated with rituximab: a case associated with hepatitis C virus infection.利妥昔单抗成功治疗难治性血栓性血小板减少性紫癜和膜增生性肾小球肾炎：1例与丙型肝炎病毒感染相关的病例
Hong Kong Med J. 2009 Jun;15(3):201-8.
6
Child-onset and adolescent-onset acquired thrombotic thrombocytopenic purpura with severe ADAMTS13 deficiency: a cohort study of the French national registry for thrombotic microangiopathy.儿童期和青少年期起病的获得性血栓性血小板减少性紫癜伴严重ADAMTS13缺乏症：法国全国血栓性微血管病登记处的一项队列研究
Lancet Haematol. 2016 Nov;3(11):e537-e546. doi: 10.1016/S2352-3026(16)30125-9. Epub 2016 Oct 3.
7
Successful treatment of relapsing autoimmune thrombotic thrombocytopenic purpura with rituximab.利妥昔单抗成功治疗复发性自身免疫性血栓性血小板减少性紫癜
Pediatr Int. 2014 Dec;56(6):914-918. doi: 10.1111/ped.12344.
8
Successful repeat therapy with rituximab for relapsed thrombotic thrombocytopenic purpura.利妥昔单抗成功重复治疗复发性血栓性血小板减少性紫癜。
J Clin Apher. 2007 Feb;22(1):17-20. doi: 10.1002/jca.20113.
9
Rituximab for the treatment of refractory idiopathic thrombocytopenic purpura (ITP) and thrombotic thrombocytopenic purpura (TTP): report of three cases.利妥昔单抗治疗难治性特发性血小板减少性紫癜（ITP）和血栓性血小板减少性紫癜（TTP）：三例报告
Am J Hematol. 2005 Jan;78(1):49-54. doi: 10.1002/ajh.20243.
10
Clopidogrel-induced refractory thrombotic thrombocytopenic purpura successfully treated with rituximab.利妥昔单抗成功治疗氯吡格雷诱导的难治性血栓性血小板减少性紫癜。
Hematol Oncol Stem Cell Ther. 2016 Jun;9(2):76-9. doi: 10.1016/j.hemonc.2015.11.003. Epub 2015 Dec 2.

本文引用的文献

1
Preemptive rituximab prevents long-term relapses in immune-mediated thrombotic thrombocytopenic purpura.预防性利妥昔单抗可预防免疫介导性血栓性血小板减少性紫癜的长期复发。
Blood. 2018 Nov 15;132(20):2143-2153. doi: 10.1182/blood-2018-04-840090. Epub 2018 Sep 10.
2
Rituximab prophylaxis to prevent thrombotic thrombocytopenic purpura relapse: outcome and evaluation of dosing regimens.利妥昔单抗预防血栓性血小板减少性紫癜复发：治疗结果及给药方案评估
Blood Adv. 2017 Jun 26;1(15):1159-1166. doi: 10.1182/bloodadvances.2017008268. eCollection 2017 Jun 27.
3
Embolic strokes of undetermined source in young adults: baseline characteristics and long-term outcome.
青年不明来源栓塞性卒中：基线特征和长期预后。
Eur J Neurol. 2018 Mar;25(3):535-541. doi: 10.1111/ene.13540. Epub 2018 Jan 19.
4
Incidental Thrombotic Thrombocytopenic Purpura during Acute Ischemic Stroke and Thrombolytic Treatment.急性缺血性卒中及溶栓治疗期间的伴发血栓性血小板减少性紫癜
J Stroke Cerebrovasc Dis. 2018 May;27(5):1417-1419. doi: 10.1016/j.jstrokecerebrovasdis.2017.10.032. Epub 2017 Nov 28.
5
Recombinant ADAMTS-13: first-in-human pharmacokinetics and safety in congenital thrombotic thrombocytopenic purpura.重组ADAMTS-13：先天性血栓性血小板减少性紫癜的首次人体药代动力学和安全性研究
Blood. 2017 Nov 9;130(19):2055-2063. doi: 10.1182/blood-2017-06-788026. Epub 2017 Sep 14.
6
Pathophysiology of thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜的病理生理学
Blood. 2017 Sep 7;130(10):1181-1188. doi: 10.1182/blood-2017-04-636431. Epub 2017 Aug 2.
7
Caplacizumab reduces the frequency of major thromboembolic events, exacerbations and death in patients with acquired thrombotic thrombocytopenic purpura.卡普雷珠单抗可降低获得性血栓性血小板减少性紫癜患者的主要血栓栓塞事件、恶化事件和死亡的发生频率。
J Thromb Haemost. 2017 Jul;15(7):1448-1452. doi: 10.1111/jth.13716. Epub 2017 Jun 5.
8
Thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜。
Blood. 2017 May 25;129(21):2836-2846. doi: 10.1182/blood-2016-10-709857. Epub 2017 Apr 17.
9
Thrombotic thrombocytopenic purpura.血栓性血小板减少性紫癜。
Nat Rev Dis Primers. 2017 Apr 6;3:17020. doi: 10.1038/nrdp.2017.20.
10
Thrombotic Thrombocytopenic Purpura with Concomitant Progressive Cerebral Microbleeds.伴有进行性脑微出血的血栓性血小板减少性紫癜
J Stroke Cerebrovasc Dis. 2016 Nov;25(11):e214-e215. doi: 10.1016/j.jstrokecerebrovasdis.2016.08.037. Epub 2016 Sep 28.